MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,552 | -88.5% | 10,481 | -90.4% | 0.00% | -91.7% |
| Q2 2023 | $3,955,910 | +437.1% | 109,491 | +452.7% | 0.01% | +300.0% |
| Q1 2023 | $736,536 | -35.0% | 19,810 | -20.8% | 0.00% | -25.0% |
| Q4 2022 | $1,132,750 | -47.5% | 25,000 | -19.1% | 0.00% | -60.0% |
| Q3 2022 | $2,158,000 | -70.3% | 30,895 | -71.5% | 0.01% | -67.7% |
| Q2 2022 | $7,273,000 | +51.6% | 108,354 | +396.3% | 0.03% | +47.6% |
| Q4 2020 | $4,796,000 | +17.2% | 21,831 | -11.4% | 0.02% | +31.2% |
| Q3 2020 | $4,092,000 | -54.8% | 24,644 | -68.9% | 0.02% | -65.2% |
| Q2 2020 | $9,054,000 | +1399.0% | 79,304 | +909.0% | 0.05% | +1050.0% |
| Q1 2020 | $604,000 | -86.7% | 7,860 | -86.5% | 0.00% | -76.5% |
| Q3 2019 | $4,550,000 | +327.2% | 58,395 | +301.6% | 0.02% | +325.0% |
| Q1 2019 | $1,065,000 | +38.0% | 14,539 | -20.1% | 0.00% | +33.3% |
| Q4 2018 | $772,000 | -4.8% | 18,200 | +5.8% | 0.00% | 0.0% |
| Q3 2018 | $811,000 | – | 17,209 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |